Our Work

The Hopkins Business of Health Initiative and the Hopkins Economics of Alzheimer’s Disease and Services Center have assembled experts to lay the groundwork to inform action steps that would best leverage the opportunities and limit the challenges tied to the approval of aducanumab. 

Telehealth policy changes, rapid mobile technology developments, and consumer demand for virtual behavioral health services are driving a proliferation of digital behavioral health services, including virtual service delivery platforms and mHealth applications, which includes FDA-approved digital therapeutics.

Join us for a co-sponsored seminar of the Hopkins Business of Health Initiative (HBHI) and Hopkins’ Economics of Alzheimer’s Disease & Services (HEADS) Center.